It’s definitely doing something that’s concerning,” one scientist said about reported side effects of the drug.

Recent health news highlights major developments in pharmaceuticals, including Merck's promising Winrevair for pulmonary ...

Positive study results for Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent ...

Merck's new formulation could help secure a larger share of Keytruda's sales after the cancer drug's U.S. patent expires in ...

The technology is already established in other fields, such as image processing ... to find new uses for drugs already in the pipeline at the Japanese pharma. And Merck’s German rival Bayer ...

Key Takeaways Merck's stock rose 2% Monday on the back of positive data from a study of a new hypertension drug. MRK stock ...

For Merck, an injectable formulation would help the company hold on to some market share and revenue that will be lost when biosimilar versions of the drug become available. In pursuing an ...

Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer drug Keytruda. Rahway, N.J.-based Merck MRK said a trial of the drug ...

Merck MRK announced that it has entered into an exclusive licensing deal with China-based privately-held biotech company ...